Are we negating the benefits of CABG by forgetting secondary prevention?

P R Belcher1, A Gaw, M Cooper

  • 1Department of Cardiac Surgery, University of Glasgow, Glasgow, UK.

Insights

Secondary prevention after coronary artery bypass grafting (CABG) was inadequately implemented one year post-surgery. Despite improvements in some areas, medication adherence and overall effectiveness were suboptimal, indicating a need for improved patient management strategies.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Medical Secondary Prevention

Background:

  • Coronary artery bypass grafting (CABG) is a major cardiovascular intervention.
  • Effective secondary prevention is crucial for long-term patient outcomes post-CABG.
  • Assessing adherence to secondary prevention guidelines is vital for patient health.

Purpose of the Study:

  • To evaluate the effectiveness of medically managed secondary prevention strategies one year after coronary artery bypass grafting (CABG).
  • To identify changes in medication use and symptom prevalence in patients post-CABG.

Main Methods:

  • A cohort of 214 patients undergoing elective isolated CABG was studied.
  • Patients were assessed four weeks preoperatively and one year post-operatively.
  • Data collected included blood pressure, anginal symptoms, breathlessness, and medication usage.

Main Results:

  • Systolic and diastolic blood pressure increased post-CABG, and anginal symptoms remained prevalent (45.1%).
  • While breathlessness decreased, medication adherence for secondary prevention, including aspirin and nitrates, was lower postoperatively.
  • Statin prescribing increased, leading to improved lipid profiles, but other key secondary prevention measures were underutilized.

Conclusions:

  • Secondary prevention measures one year after CABG were poorly applied, less widespread, and less effective than preoperatively.
  • Angina remains a common issue, highlighting gaps in postoperative care.
  • The findings suggest disturbing implications for long-term cardiovascular health in post-CABG patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...